Eritrea vs Senegal: Cause of death, by non-communicable diseases, ages 60+, male
Eritrea
60.7%
in 2021
Senegal
61.4%
in 2021
Eritrea rank
132nd
Senegal rank
129th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Eritrea
- Senegal
How they compare
Senegal currently reports 61.4% against 60.7% in Eritrea, a difference of 0.7%.
Across all 6 years both countries report, Senegal has been ahead every year.
Eritrea ranks 132nd and Senegal ranks 129th of 185 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.3% | 69.0% | 6.7% | Senegal |
| 2010s | 64.4% | 74.8% | 10.4% | Senegal |
| 2020s | 62.2% | 66.4% | 4.2% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Eritrea or Senegal?
- Senegal, at 61.4% against 60.7% in Eritrea as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Eritrea and Senegal?
- 0.7%, with Senegal ahead.
- How many years of comparable data are there for Eritrea and Senegal?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and Senegal rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Eritrea ranks 132nd and Senegal ranks 129th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.